The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation

Asthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side effects highlight the need for additional therapeutic strategies. Environmental exposures such as traditional farm dust have been linked to protect...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Allergy (Copenhagen)
Hlavní autori:	Korkmaz, Rabia Ülkü, Omony, Jimmy, Tan, Xiaomei, Klotz, Markus, Dragunas, Guilherme, Chen, Sirui, Shankhwar, Soni, Ertüz, Zeynep, Müller, Christoph, Ragab, Mohab, Jeridi, Aicha, Augustin, Romina, Nawroth, Janna, Kapellos, Theodore S., Rankl, Bettina, Yildirim, Ali Önder, von Mutius, Erika
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Denmark 22.10.2025
Predmet:	regulatory T cells prophylactic intervention asthma epithelial barrier Th2 inflammation farm dust extract
ISSN:	0105-4538, 1398-9995, 1398-9995
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Asthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side effects highlight the need for additional therapeutic strategies. Environmental exposures such as traditional farm dust have been linked to protection against asthma and allergies. This study investigated the therapeutic potential of farm dust extract (FDE) in a murine model of allergic asthma when administered after sensitization and during allergen challenge, mimicking a secondary prevention or early interventional treatment approach. We used an ovalbumin (OVA)-induced asthma model to evaluate FDE effects on airway eosinophilia, airway hyperresponsiveness (AHR), mucus production, and IgE levels. Mechanistic studies assessed regulatory T cells (Tregs), dendritic cell phenotype, epithelial barrier integrity, and cytokine signaling. Complementary experiments were performed in peripheral blood mononuclear cells (PBMCs) from asthmatic donors. FDE significantly reduced airway inflammation and AHR, with secondary prevention effects comparable to systemic dexamethasone. FDE enhanced Treg frequency and CTLA-4 expression, modulated dendritic cell MHC-II and PD-L1 expression, and promoted an immunoregulatory environment. It also restored epithelial barrier integrity and increased IL-33 release, supporting Treg activation. In asthmatic PBMCs, FDE increased Tregs, reduced Th2 cells, and suppressed CIITA, suggesting similar immune-regulatory effects. Interactions among IL-33, amphiregulin (AREG), and Tregs highlighted a mechanism reinforcing immune-epithelial homeostasis. FDE administered after sensitization and during allergen challenge mitigated key asthma features in mice and showed translational potential in human cells, supporting its development as a novel, environmentally derived immunomodulatory strategy.
AbstractList	Asthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side effects highlight the need for additional therapeutic strategies. Environmental exposures such as traditional farm dust have been linked to protection against asthma and allergies. This study investigated the therapeutic potential of farm dust extract (FDE) in a murine model of allergic asthma when administered after sensitization and during allergen challenge, mimicking a secondary prevention or early interventional treatment approach.BACKGROUNDAsthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side effects highlight the need for additional therapeutic strategies. Environmental exposures such as traditional farm dust have been linked to protection against asthma and allergies. This study investigated the therapeutic potential of farm dust extract (FDE) in a murine model of allergic asthma when administered after sensitization and during allergen challenge, mimicking a secondary prevention or early interventional treatment approach.We used an ovalbumin (OVA)-induced asthma model to evaluate FDE effects on airway eosinophilia, airway hyperresponsiveness (AHR), mucus production, and IgE levels. Mechanistic studies assessed regulatory T cells (Tregs), dendritic cell phenotype, epithelial barrier integrity, and cytokine signaling. Complementary experiments were performed in peripheral blood mononuclear cells (PBMCs) from asthmatic donors.METHODSWe used an ovalbumin (OVA)-induced asthma model to evaluate FDE effects on airway eosinophilia, airway hyperresponsiveness (AHR), mucus production, and IgE levels. Mechanistic studies assessed regulatory T cells (Tregs), dendritic cell phenotype, epithelial barrier integrity, and cytokine signaling. Complementary experiments were performed in peripheral blood mononuclear cells (PBMCs) from asthmatic donors.FDE significantly reduced airway inflammation and AHR, with secondary prevention effects comparable to systemic dexamethasone. FDE enhanced Treg frequency and CTLA-4 expression, modulated dendritic cell MHC-II and PD-L1 expression, and promoted an immunoregulatory environment. It also restored epithelial barrier integrity and increased IL-33 release, supporting Treg activation. In asthmatic PBMCs, FDE increased Tregs, reduced Th2 cells, and suppressed CIITA, suggesting similar immune-regulatory effects. Interactions among IL-33, amphiregulin (AREG), and Tregs highlighted a mechanism reinforcing immune-epithelial homeostasis.RESULTSFDE significantly reduced airway inflammation and AHR, with secondary prevention effects comparable to systemic dexamethasone. FDE enhanced Treg frequency and CTLA-4 expression, modulated dendritic cell MHC-II and PD-L1 expression, and promoted an immunoregulatory environment. It also restored epithelial barrier integrity and increased IL-33 release, supporting Treg activation. In asthmatic PBMCs, FDE increased Tregs, reduced Th2 cells, and suppressed CIITA, suggesting similar immune-regulatory effects. Interactions among IL-33, amphiregulin (AREG), and Tregs highlighted a mechanism reinforcing immune-epithelial homeostasis.FDE administered after sensitization and during allergen challenge mitigated key asthma features in mice and showed translational potential in human cells, supporting its development as a novel, environmentally derived immunomodulatory strategy.CONCLUSIONFDE administered after sensitization and during allergen challenge mitigated key asthma features in mice and showed translational potential in human cells, supporting its development as a novel, environmentally derived immunomodulatory strategy. Asthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side effects highlight the need for additional therapeutic strategies. Environmental exposures such as traditional farm dust have been linked to protection against asthma and allergies. This study investigated the therapeutic potential of farm dust extract (FDE) in a murine model of allergic asthma when administered after sensitization and during allergen challenge, mimicking a secondary prevention or early interventional treatment approach. We used an ovalbumin (OVA)-induced asthma model to evaluate FDE effects on airway eosinophilia, airway hyperresponsiveness (AHR), mucus production, and IgE levels. Mechanistic studies assessed regulatory T cells (Tregs), dendritic cell phenotype, epithelial barrier integrity, and cytokine signaling. Complementary experiments were performed in peripheral blood mononuclear cells (PBMCs) from asthmatic donors. FDE significantly reduced airway inflammation and AHR, with secondary prevention effects comparable to systemic dexamethasone. FDE enhanced Treg frequency and CTLA-4 expression, modulated dendritic cell MHC-II and PD-L1 expression, and promoted an immunoregulatory environment. It also restored epithelial barrier integrity and increased IL-33 release, supporting Treg activation. In asthmatic PBMCs, FDE increased Tregs, reduced Th2 cells, and suppressed CIITA, suggesting similar immune-regulatory effects. Interactions among IL-33, amphiregulin (AREG), and Tregs highlighted a mechanism reinforcing immune-epithelial homeostasis. FDE administered after sensitization and during allergen challenge mitigated key asthma features in mice and showed translational potential in human cells, supporting its development as a novel, environmentally derived immunomodulatory strategy.
Author	Ragab, Mohab Korkmaz, Rabia Ülkü Müller, Christoph Kapellos, Theodore S. Nawroth, Janna Ertüz, Zeynep Rankl, Bettina Chen, Sirui Augustin, Romina Yildirim, Ali Önder Tan, Xiaomei Dragunas, Guilherme Shankhwar, Soni Omony, Jimmy von Mutius, Erika Klotz, Markus Jeridi, Aicha
Author_xml	– sequence: 1 givenname: Rabia Ülkü orcidid: 0000-0002-2566-5346 surname: Korkmaz fullname: Korkmaz, Rabia Ülkü organization: Helmholtz Zentrum München, Research Center for Environmental Health Institute of Asthma and Allergy Prevention Neuherberg Germany – sequence: 2 givenname: Jimmy surname: Omony fullname: Omony, Jimmy organization: Helmholtz Zentrum München, Research Center for Environmental Health Institute of Asthma and Allergy Prevention Neuherberg Germany – sequence: 3 givenname: Xiaomei surname: Tan fullname: Tan, Xiaomei organization: Comprehensive Pneumology Center (CPC‐M) Institute of Lung Health and Immunity (LHI), Helmholtz Munich Munich Germany – sequence: 4 givenname: Markus surname: Klotz fullname: Klotz, Markus organization: Comprehensive Pneumology Center (CPC‐M) Institute of Lung Health and Immunity (LHI), Helmholtz Munich Munich Germany – sequence: 5 givenname: Guilherme orcidid: 0000-0001-6560-8402 surname: Dragunas fullname: Dragunas, Guilherme organization: Comprehensive Pneumology Center (CPC‐M) Institute of Lung Health and Immunity (LHI), Helmholtz Munich Munich Germany – sequence: 6 givenname: Sirui surname: Chen fullname: Chen, Sirui organization: Comprehensive Pneumology Center (CPC‐M) Institute of Lung Health and Immunity (LHI), Helmholtz Munich Munich Germany – sequence: 7 givenname: Soni surname: Shankhwar fullname: Shankhwar, Soni organization: Helmholtz Zentrum München, Research Center for Environmental Health Institute of Asthma and Allergy Prevention Neuherberg Germany – sequence: 8 givenname: Zeynep surname: Ertüz fullname: Ertüz, Zeynep organization: Comprehensive Pneumology Center (CPC‐M) Institute of Lung Health and Immunity (LHI), Helmholtz Munich Munich Germany – sequence: 9 givenname: Christoph surname: Müller fullname: Müller, Christoph organization: Department of Pharmacy—Center for Drug Research Ludwig‐Maximilians Universität München Munich Germany – sequence: 10 givenname: Mohab surname: Ragab fullname: Ragab, Mohab organization: Department of Internal Medicine II, TUM University Hospital, Klinikum Rechts der Isar, TUM School of Medicine and Health Technical University of Munich Munich Germany – sequence: 11 givenname: Aicha surname: Jeridi fullname: Jeridi, Aicha organization: Comprehensive Pneumology Center (CPC‐M) Institute of Lung Health and Immunity (LHI), Helmholtz Munich Munich Germany, German Center for Lung Research (DZL) Munich Germany – sequence: 12 givenname: Romina surname: Augustin fullname: Augustin, Romina organization: German Center for Lung Research (DZL) Munich Germany, Helmholtz Pioneer Campus Helmholtz Zentrum München Neuherberg Germany, Institute of Biological and Medical Imaging Bioengineering Center, Helmholtz Zentrum München Neuherberg Germany, Chair of Biological Imaging at the Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health Technical University of Munich Munich Germany, Faculty of Engineering Sciences University of Heidelberg Heidelberg Germany – sequence: 13 givenname: Janna surname: Nawroth fullname: Nawroth, Janna organization: German Center for Lung Research (DZL) Munich Germany, Helmholtz Pioneer Campus Helmholtz Zentrum München Neuherberg Germany, Institute of Biological and Medical Imaging Bioengineering Center, Helmholtz Zentrum München Neuherberg Germany, Chair of Biological Imaging at the Central Institute for Translational Cancer Research (TranslaTUM), School of Medicine and Health Technical University of Munich Munich Germany – sequence: 14 givenname: Theodore S. surname: Kapellos fullname: Kapellos, Theodore S. organization: Comprehensive Pneumology Center (CPC‐M) Institute of Lung Health and Immunity (LHI), Helmholtz Munich Munich Germany, German Center for Lung Research (DZL) Munich Germany, Institute of Experimental Pneumology, LMU University Hospital Ludwig‐Maximilian's University Munich Germany – sequence: 15 givenname: Bettina surname: Rankl fullname: Rankl, Bettina organization: Helmholtz Zentrum München, Research Center for Environmental Health Institute of Asthma and Allergy Prevention Neuherberg Germany – sequence: 16 givenname: Ali Önder orcidid: 0000-0003-1969-480X surname: Yildirim fullname: Yildirim, Ali Önder organization: Comprehensive Pneumology Center (CPC‐M) Institute of Lung Health and Immunity (LHI), Helmholtz Munich Munich Germany, German Center for Lung Research (DZL) Munich Germany, Institute of Experimental Pneumology, LMU University Hospital Ludwig‐Maximilian's University Munich Germany – sequence: 17 givenname: Erika surname: von Mutius fullname: von Mutius, Erika organization: Helmholtz Zentrum München, Research Center for Environmental Health Institute of Asthma and Allergy Prevention Neuherberg Germany, German Center for Lung Research (DZL) Munich Germany, Ludwig‐Maximilians University Dr. von Hauner Children's Hospital Munich Germany
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/41123048$$D View this record in MEDLINE/PubMed
BookMark	eNo9kMtOwzAQRS1URB-w4AeQl7BI8SuOs0SlhUpFsOgWRU5iq0aOXWJHgr_HtIWRZmZzdDVzpmDkvFMAXGM0x6nupbXzAmGCz8AE01JkZVnmIzBBGOUZy6kYg2kIHwihgpToAowZxoQiJibgfbtTMHUv92qIpoFvPioXjbTQa7iSfQcfhxDh8iv2sokBGgclfPFDUGm26oAtfTDO73fGpoC101Z2nYzGu0twrqUN6uq0Z2C7Wm4Xz9nm9Wm9eNhkDREkZpgLRZjGghSE8obTkuWCipazmtZFyWsmiOBaY6ZQzXlLVPpSNkITKosc0Rm4Pcbue_85qBCrzoRGWSudSpdWlHAqkhPKEnpzQoe6U221700n--_qz0gC7o5A0_sQeqX_EYyqX9tVsl0dbNMfJAtvug
Cites_doi	10.1038/s41587‐023‐01767‐y 10.3390/biom14050546 10.4049/jimmunol.0802387 10.1038/nature13577 10.1111/all.15076 10.1056/NEJMoa020057 10.3390/ijms232214185 10.1016/j.jneuroim.2014.06.005 10.1136/bmj.j1415 10.1016/j.jaci.2021.03.044 10.1016/j.jaci.2004.07.014 10.3389/fimmu.2016.00440 10.1038/s41598‐022‐15393‐2 10.1186/1465‐9921‐7‐59 10.1186/s12865‐024‐00644‐w 10.3389/fimmu.2024.1351405 10.1016/j.immuni.2015.01.020 10.1038/nri.2017.1 10.1038/nbt.4314 10.1093/bmb/ldaa004 10.1002/hep.22437 10.1016/j.jaip.2021.10.032 10.1038/mi.2010.51 10.1002/ski2.440 10.1165/ajrcmb.17.3.2679 10.1016/j.bbrc.2009.06.008 10.1016/j.jaci.2009.11.017 10.3390/ijms25063191 10.4168/aair.2019.11.3.381 10.1016/j.jaci.2023.05.013 10.1371/journal.pone.0172446 10.1002/jlb.1mr1117‐442rr 10.1016/j.jaci.2021.01.026 10.1056/NEJMoa1007302 10.1513/pats.200504‐028SR 10.1016/j.jaci.2022.07.022 10.1038/mi.2012.119 10.1042/bsr20231331 10.3389/fimmu.2012.00051 10.1126/science.aac6623 10.1111/imr.13380 10.1371/journal.pone.0077322 10.1111/all.15670 10.1016/s0091‐6749(99)70138‐7 10.1016/j.cyto.2022.155891 10.1189/jlb.3VMR1214‐600RR 10.4049/jimmunol.1601691 10.1111/all.16347 10.1016/j.jaci.2019.07.034 10.1136/thx.2005.049403 10.3390/cancers13061440 10.1073/pnas.2023739118 10.1016/j.jaci.2021.09.013 10.3389/fphys.2022.1059686 10.1371/journal.pone.0184956 10.4049/jimmunol.174.3.1205 10.1186/1465‐9921‐8‐71 10.1089/omi.2011.0118 10.1056/NEJMoa1508749 10.1016/j.immuni.2005.09.015 10.1016/j.jaci.2017.09.022 10.3389/fimmu.2017.01578 10.1097/00004836‐200110000‐00006 10.1111/cea.12526 10.3390/ijms19092793 10.3390/cells9020300 10.1002/14651858.CD010126.pub2 10.1016/j.jaip.2018.01.025 10.4049/jimmunol.178.1.463 10.3389/fimmu.2023.1163633 10.1183/13993003.01397‐2023 10.1007/s10529‐019‐02743‐w 10.1016/j.immuni.2012.09.023 10.1186/s40425‐018‐0371‐5 10.1182/blood‐2004‐05‐2044 10.3389/fimmu.2019.02839
ContentType	Journal Article
Copyright	2025 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Copyright_xml	– notice: 2025 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
DBID	AAYXX CITATION NPM 7X8
DOI	10.1111/all.70121
DatabaseName	CrossRef PubMed MEDLINE - Academic
DatabaseTitle	CrossRef PubMed MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic PubMed
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1398-9995
ExternalDocumentID	41123048 10_1111_all_70121
Genre	Journal Article
GrantInformation_xml	– fundername: European Research Council – fundername: German Center for Lung Research – fundername: German Center for Lung Research (DZL) – fundername: Federal Ministry of Education and Research
GroupedDBID	.3N .GA 05W 0R~ 10A 1OB 1OC 23M 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AAXRX AAYCA AAYXX AAZKR ABCQN ABCUV ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CITATION CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HGLYW HZI HZ~ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O8X O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI WXSBR XG1 ZZTAW ~IA ~KM ~WT ALUQN NPM 7X8
ID	FETCH-LOGICAL-c282t-168e24f1827236c63945838d64b3b796b48286ff14e0b66d2e139ac8f23a7503
ISICitedReferencesCount	0
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001597431800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0105-4538 1398-9995
IngestDate	Sat Oct 25 04:52:57 EDT 2025 Sat Oct 25 05:58:49 EDT 2025 Sat Nov 29 07:06:55 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Keywords	regulatory T cells prophylactic intervention asthma epithelial barrier Th2 inflammation farm dust extract
Language	English
License	2025 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c282t-168e24f1827236c63945838d64b3b796b48286ff14e0b66d2e139ac8f23a7503
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ORCID	0000-0003-1969-480X 0000-0002-2566-5346 0000-0001-6560-8402
OpenAccessLink	https://doi.org/10.1111/all.70121
PMID	41123048
PQID	3263899934
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_3263899934 pubmed_primary_41123048 crossref_primary_10_1111_all_70121
PublicationCentury	2000
PublicationDate	2025-10-22
PublicationDateYYYYMMDD	2025-10-22
PublicationDate_xml	– month: 10 year: 2025 text: 2025-10-22 day: 22
PublicationDecade	2020
PublicationPlace	Denmark
PublicationPlace_xml	– name: Denmark
PublicationTitle	Allergy (Copenhagen)
PublicationTitleAlternate	Allergy
PublicationYear	2025
References	e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_69_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_42_1 e_1_2_10_40_1 Han Y. (e_1_2_10_36_1) 2020; 10 e_1_2_10_70_1 e_1_2_10_2_1 e_1_2_10_72_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_74_1 e_1_2_10_53_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_76_1 e_1_2_10_55_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_57_1 e_1_2_10_78_1 e_1_2_10_58_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_30_1 e_1_2_10_51_1 e_1_2_10_61_1 e_1_2_10_29_1 e_1_2_10_63_1 e_1_2_10_27_1 e_1_2_10_65_1 e_1_2_10_25_1 e_1_2_10_48_1 e_1_2_10_67_1 e_1_2_10_24_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 e_1_2_10_71_1 e_1_2_10_73_1 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_75_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_77_1 e_1_2_10_56_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_59_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_31_1 e_1_2_10_50_1 e_1_2_10_60_1 e_1_2_10_62_1 e_1_2_10_64_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_66_1 e_1_2_10_26_1 e_1_2_10_47_1 e_1_2_10_68_1
References_xml	– ident: e_1_2_10_76_1 doi: 10.1038/s41587‐023‐01767‐y – ident: e_1_2_10_20_1 doi: 10.3390/biom14050546 – ident: e_1_2_10_44_1 doi: 10.4049/jimmunol.0802387 – ident: e_1_2_10_43_1 doi: 10.1038/nature13577 – ident: e_1_2_10_8_1 doi: 10.1111/all.15076 – ident: e_1_2_10_11_1 doi: 10.1056/NEJMoa020057 – ident: e_1_2_10_68_1 doi: 10.3390/ijms232214185 – ident: e_1_2_10_67_1 doi: 10.1016/j.jneuroim.2014.06.005 – ident: e_1_2_10_9_1 doi: 10.1136/bmj.j1415 – ident: e_1_2_10_42_1 doi: 10.1016/j.jaci.2021.03.044 – ident: e_1_2_10_57_1 doi: 10.1016/j.jaci.2004.07.014 – ident: e_1_2_10_39_1 doi: 10.3389/fimmu.2016.00440 – ident: e_1_2_10_52_1 doi: 10.1038/s41598‐022‐15393‐2 – ident: e_1_2_10_46_1 doi: 10.1186/1465‐9921‐7‐59 – ident: e_1_2_10_56_1 doi: 10.1186/s12865‐024‐00644‐w – ident: e_1_2_10_41_1 doi: 10.3389/fimmu.2024.1351405 – ident: e_1_2_10_26_1 doi: 10.1016/j.immuni.2015.01.020 – ident: e_1_2_10_5_1 doi: 10.1038/nri.2017.1 – ident: e_1_2_10_77_1 doi: 10.1038/nbt.4314 – ident: e_1_2_10_2_1 doi: 10.1093/bmb/ldaa004 – ident: e_1_2_10_54_1 doi: 10.1002/hep.22437 – ident: e_1_2_10_6_1 doi: 10.1016/j.jaip.2021.10.032 – ident: e_1_2_10_61_1 doi: 10.1038/mi.2010.51 – ident: e_1_2_10_75_1 doi: 10.1002/ski2.440 – ident: e_1_2_10_28_1 doi: 10.1165/ajrcmb.17.3.2679 – ident: e_1_2_10_65_1 doi: 10.1016/j.bbrc.2009.06.008 – ident: e_1_2_10_21_1 doi: 10.1016/j.jaci.2009.11.017 – ident: e_1_2_10_23_1 doi: 10.3390/ijms25063191 – ident: e_1_2_10_47_1 doi: 10.4168/aair.2019.11.3.381 – ident: e_1_2_10_15_1 doi: 10.1016/j.jaci.2023.05.013 – ident: e_1_2_10_73_1 doi: 10.1371/journal.pone.0172446 – ident: e_1_2_10_17_1 doi: 10.1002/jlb.1mr1117‐442rr – ident: e_1_2_10_30_1 doi: 10.1016/j.jaci.2021.01.026 – ident: e_1_2_10_10_1 doi: 10.1056/NEJMoa1007302 – ident: e_1_2_10_50_1 doi: 10.1513/pats.200504‐028SR – ident: e_1_2_10_59_1 doi: 10.1016/j.jaci.2022.07.022 – ident: e_1_2_10_71_1 doi: 10.1038/mi.2012.119 – ident: e_1_2_10_37_1 doi: 10.1042/bsr20231331 – ident: e_1_2_10_27_1 doi: 10.3389/fimmu.2012.00051 – ident: e_1_2_10_14_1 doi: 10.1126/science.aac6623 – ident: e_1_2_10_22_1 doi: 10.1111/imr.13380 – ident: e_1_2_10_29_1 doi: 10.1371/journal.pone.0077322 – ident: e_1_2_10_18_1 doi: 10.1111/all.15670 – ident: e_1_2_10_66_1 doi: 10.1016/s0091‐6749(99)70138‐7 – ident: e_1_2_10_40_1 doi: 10.1016/j.cyto.2022.155891 – ident: e_1_2_10_48_1 doi: 10.1189/jlb.3VMR1214‐600RR – ident: e_1_2_10_25_1 doi: 10.4049/jimmunol.1601691 – ident: e_1_2_10_16_1 doi: 10.1111/all.16347 – ident: e_1_2_10_60_1 doi: 10.1016/j.jaci.2019.07.034 – ident: e_1_2_10_12_1 doi: 10.1136/thx.2005.049403 – ident: e_1_2_10_31_1 doi: 10.3390/cancers13061440 – ident: e_1_2_10_58_1 doi: 10.1073/pnas.2023739118 – volume: 10 start-page: 727 year: 2020 ident: e_1_2_10_36_1 article-title: PD‐1/PD‐L1 Pathway: Current Researches in Cancer publication-title: American Journal of Cancer Research – ident: e_1_2_10_62_1 doi: 10.1016/j.jaci.2021.09.013 – ident: e_1_2_10_49_1 doi: 10.3389/fphys.2022.1059686 – ident: e_1_2_10_72_1 doi: 10.1371/journal.pone.0184956 – ident: e_1_2_10_24_1 doi: 10.4049/jimmunol.174.3.1205 – ident: e_1_2_10_63_1 doi: 10.1186/1465‐9921‐8‐71 – ident: e_1_2_10_78_1 doi: 10.1089/omi.2011.0118 – ident: e_1_2_10_13_1 doi: 10.1056/NEJMoa1508749 – ident: e_1_2_10_45_1 doi: 10.1016/j.immuni.2005.09.015 – ident: e_1_2_10_19_1 doi: 10.1016/j.jaci.2017.09.022 – ident: e_1_2_10_32_1 doi: 10.3389/fimmu.2017.01578 – ident: e_1_2_10_7_1 doi: 10.1097/00004836‐200110000‐00006 – ident: e_1_2_10_69_1 doi: 10.1111/cea.12526 – ident: e_1_2_10_64_1 doi: 10.3390/ijms19092793 – ident: e_1_2_10_70_1 doi: 10.3390/cells9020300 – ident: e_1_2_10_4_1 doi: 10.1002/14651858.CD010126.pub2 – ident: e_1_2_10_3_1 doi: 10.1016/j.jaip.2018.01.025 – ident: e_1_2_10_38_1 doi: 10.4049/jimmunol.178.1.463 – ident: e_1_2_10_35_1 doi: 10.3389/fimmu.2023.1163633 – ident: e_1_2_10_51_1 doi: 10.1183/13993003.01397‐2023 – ident: e_1_2_10_74_1 doi: 10.1007/s10529‐019‐02743‐w – ident: e_1_2_10_55_1 doi: 10.1016/j.immuni.2012.09.023 – ident: e_1_2_10_53_1 doi: 10.1186/s40425‐018‐0371‐5 – ident: e_1_2_10_33_1 doi: 10.1182/blood‐2004‐05‐2044 – ident: e_1_2_10_34_1 doi: 10.3389/fimmu.2019.02839
SSID	ssj0007290
Score	2.4784732
SecondaryResourceType	online_first
Snippet	Asthma affects over 355 million people globally and poses a major healthcare burden. While corticosteroids remain a cornerstone of treatment, their side...
SourceID	proquest pubmed crossref
SourceType	Aggregation Database Index Database
Title	The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation
URI	https://www.ncbi.nlm.nih.gov/pubmed/41123048 https://www.proquest.com/docview/3263899934
WOSCitedRecordID	wos001597431800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 0105-4538 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1398-9995 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007290 issn: 0105-4538 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Lb9MwGLfYhtAuiDcdMBnErcrUJM7DR-haITEGmgLqBUWOY0O0xqmaFPXP57OdRwuaNA5c0ipKnNbfL9_7gdBbwqTIhcucnPLIITTOHZrB-5jz2HUFdzNpyse-XUSXl_FiQbuIbm3GCURKxdstXf1XUsM5ILYunf0HcveLwgn4DkSHI5AdjrcmfDJUVY2_VI3OCLJK55yty_H5pm7Gs22jC6RMOiyDV3tTCzMYzVw2q-pCVSvtbOHAQiTAphxI2DWt1VWEP0y2wFQP4foJrEnteBY-VuvrkhkH9RXLCjbWQXk6XV7rz_e9d_Yz7Iwdm1yUQ3lFYh2zi4JVpSj6JZeVmT9rSoz2XRaeaXXq7XkxJ4FDAtvW5UxYzutT4LzUTty8ga-z5fIs0k3oBuHVBez_kGl9pmFn48Ctqbn1AB15UUCBAR6dX82_XvRiO2odct1va9tQ6bSv_rn7yssNFonRTJIH6H5rUuB3FgoP0R2hHqF7n9qkicfoO6AB7yAC94jAlcQaEVgjAneIwIXCDBtEYIMIfdkuIvAuIp6gZD5Lph-cdqqGw8G8bhw3jIVHJNiVkeeHHDRUEzrPQ5L5WUTDjOjOAlK6REyyMMw9AaRhPJaez3TQ-yk6VJUSzxEOqStAPuQyYAHxgRWALhi6HIzaiW6jOBmhN91upSvbOyX9ix4j9LrbxxQ4mw5XMSXgL6ZgWOjmj9QnI_TMbnC_DAEzwQfhc3KbR7xAxwMKX6LDZr0Rr9Bd_qsp6vUpOogW8WmLht-iIHX4
linkProvider	Wiley-Blackwell
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Therapeutic+Potential+of+Farm+Dust+Extracts+in+a+Mouse+Model+of+Eosinophilic+Inflammation&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Korkmaz%2C+Rabia+%C3%9Clk%C3%BC&rft.au=Omony%2C+Jimmy&rft.au=Tan%2C+Xiaomei&rft.au=Klotz%2C+Markus&rft.date=2025-10-22&rft.issn=0105-4538&rft.eissn=1398-9995&rft_id=info:doi/10.1111%2Fall.70121&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_all_70121
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon